Numerous reports have shown that the FAK gene is amplified in a large fraction of breast cancer specimens; meanwhile, increased FAK expression and activity frequently correlates with metastatic disease and poor prognosis (reviewed in [15]). The gene discussed is PTK2; the disease is breast cancer.